Podcast
Questions and Answers
For which type of drugs is gastric retention desirable?
For which type of drugs is gastric retention desirable?
- Drugs that are locally active in the stomach
- Drugs that degrade in the intestinal or colonic environment (correct)
- Drugs that have narrow absorption window in GIT
- Drugs that require rapid excretion from the body
What is the primary benefit of prolonged gastric retention for drug delivery?
What is the primary benefit of prolonged gastric retention for drug delivery?
- Faster gastric emptying
- Improved bioavailability (correct)
- Increased drug waste
- Reduced solubility
Which drug delivery system aims to overcome limited bioavailability due to fast gastric emptying time?
Which drug delivery system aims to overcome limited bioavailability due to fast gastric emptying time?
- Intestinal targeted drug delivery system
- Colon-specific drug delivery system
- Gastric retained drug delivery system (correct)
- Oral immediate release drug delivery system
Which factor contributes to the limited bioavailability of conventional oral medications?
Which factor contributes to the limited bioavailability of conventional oral medications?
What is the primary purpose of gastroretentive drug delivery systems?
What is the primary purpose of gastroretentive drug delivery systems?
What is the primary purpose of a pulsatile drug delivery system (PDDS)?
What is the primary purpose of a pulsatile drug delivery system (PDDS)?
Which type of drugs may require a lag time in drug release in a pulsatile drug delivery system?
Which type of drugs may require a lag time in drug release in a pulsatile drug delivery system?
In which portion of the gastrointestinal tract (GIT) is drug release prevented when targeting a drug to the colon?
In which portion of the gastrointestinal tract (GIT) is drug release prevented when targeting a drug to the colon?
Which diseases are targeted for pulsatile technology?
Which diseases are targeted for pulsatile technology?
What is the key characteristic of diseases requiring chronopharmacotherapy and pulsatile drug delivery systems?
What is the key characteristic of diseases requiring chronopharmacotherapy and pulsatile drug delivery systems?
